Anastrozole
Educational information only — not medical advice. Many listed compounds are not FDA-approved for human use. Consult a licensed clinician before starting, changing, or stopping any protocol.
Overview
Anastrozole is a nonsteroidal aromatase inhibitor (AI), marketed under the brand name Arimidex. It is FDA-approved for the treatment of hormone-receptor-positive breast cancer in postmenopausal women, where lowering estrogen levels can slow the growth of estrogen-sensitive tumors.
In the context of testosterone replacement therapy (TRT), anastrozole is sometimes used off-label to help manage estrogen. Because testosterone can be converted into estradiol in the body, some men on testosterone therapy develop elevated estrogen, and an aromatase inhibitor is one tool clinicians have used to address this.
Unlike many compounds discussed in this space, anastrozole is a well-characterized pharmaceutical with an established human safety and efficacy record in its approved indication. Its use in men, however, is not an approved indication and remains individualized.
How it works
Anastrozole reversibly binds to and inhibits aromatase, the enzyme responsible for converting androgens such as testosterone and androstenedione into estrogens. By blocking this conversion, it reduces circulating estradiol and estrone.
In men, aromatase inhibition has been studied for its ability to lower estradiol and raise testosterone levels. Reported effects reflect this hormonal shift rather than a direct action on testosterone production itself.
Reported benefits
- Reduced estradiol levels in men with elevated estrogen (studied)
- Higher measured testosterone levels in some studies of older or hypogonadal men
- Management of estrogen-related effects reported by some men on testosterone therapy (off-label)
- Established efficacy in its approved oncology indication
These reflect reported and studied effects, not guaranteed outcomes, and the male applications remain off-label.
Considerations & side effects
Aromatase inhibition lowers estrogen, and estrogen plays an important role in male physiology, including bone health. Studies in men have reported decreases in bone mineral density with prolonged aromatase inhibition, and some evidence suggests possible effects on insulin sensitivity and lipids. Over-suppressing estrogen can itself cause symptoms such as joint discomfort, low mood, and reduced libido.
Commonly reported side effects in the approved breast-cancer setting include hot flashes, joint pain and stiffness, fatigue, and bone thinning over time. Long-term efficacy and safety of aromatase inhibitors specifically in men have not been firmly established. Anastrozole is a prescription medication and is not a substitute for evaluation and monitoring by a qualified clinician.
Frequently asked
What is anastrozole?
A nonsteroidal aromatase inhibitor, sold under the brand name Arimidex, that lowers estrogen levels by blocking the enzyme that converts androgens into estrogen.
Is anastrozole FDA-approved?
Yes, for treating hormone-receptor-positive breast cancer in postmenopausal women. Its use in men to control estrogen during testosterone therapy is off-label and not an approved indication.
Why is anastrozole used alongside TRT?
Testosterone can be converted to estradiol by aromatase. Some clinicians use an aromatase inhibitor to manage elevated estrogen in men on testosterone therapy, though this is off-label and individualized.
Does anastrozole require a prescription?
As an FDA-approved medication, anastrozole is a prescription drug and is intended to be used under the supervision of a qualified clinician.
References
- National Cancer Institute — Anastrozole drug information ↗
- de Ronde W, de Jong FH. Aromatase inhibitors in men: effects and therapeutic options. ↗
- Herzog AG, et al. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism. ↗
Related compounds
A steroidal, irreversible ('suicide') aromatase inhibitor that lowers estradiol by permanently binding the aromatase enzyme. Used on TRT or cycles to manage high estrogen; unlike anastrozole it does not cause a rebound.
A potent non-steroidal aromatase inhibitor that strongly suppresses estradiol. Used to manage estrogen on TRT/cycles and to treat gynecomastia; because it is very powerful, low or every-other-day dosing is common to avoid crashing estrogen.
A SERM that blocks estrogen at breast tissue, used by men to prevent or treat gynecomastia and as a post-cycle therapy agent to restore the HPG axis. Unlike aromatase inhibitors it does not lower systemic estradiol.